The strategies for treating PRMS include:
Modifying the disease course
- The interferon beta medications (Avonex, Betaseron, Extavia and Rebif), Aubagio (teriflunomide), Gilenya (fingolimod), and Tecfidera (dimethyl fumarate) are all approved by the FDA for use in relapsing forms of MS, which include those individuals with progressive-relapsing MS who continue to have relapses. If the person’s physician feels that none of these first-line medications is doing an adequate job of controlling disease activity, he or she will likely recommend changing to Tysabri (natalizumab) or Novantrone (mitoxantrone).
- Regardless of the course of MS a person is experiencing, proactive symptom management is essential to maintaining comfort and productivity, and enhancing quality of life.
Enhancing mobility and promoting safety and independence
- Rehabilitation specialists have an important role, from the time of diagnosis onward, in helping people function optimally in spite of their MS
Promoting overall health and wellness
- Health and wellness can be achieved even in the presence of a chronic illness or disability.
- Promoting emotional well-being and quality of life